Hema Now | Episode 19
In this thrilling edition of the Hema Now podcast, Jonathan Sackier is joined by Lydia Scarfò, an expert in B cell disorders, to discuss her journey in haematology, what splenic marginal zone lymphoma is, and how STIL loss affects these cells and might impact future therapeutic interventions.
Apple | Amazon Music | YouTube | Download MP3 (29 mins)
Lydia Scarfò
Lydia Scarfò is a Physician Scientist at the B-cell Neoplasia Unit and an Assistant Professor at Università Vita-Salute San Raffaele, Milan, Italy.
She is involved in both clinical and pre-clinical studies, including being a co-investigator in over 20 clinical trials in haematological malignancies, including chronic lymphocytic leukaemia.
Timestamps:
0:00 – Introduction
1:14 – Quickfire questions
7:31 – Haematology inspiration
9:08 – STIL loss
11:42 – Splenic marginal zone lymphoma
13:03 – Novel targeted therapies for chronic lymphocytic leukaemia
17:35 – Covalent BTK inhibitors
19:30 – Chemo-free approach for hairy cell leukaemia
22:20 – Recent advances, challenges, and opportunities
25:58 – Three wishes
The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
